IL2-receptor antagonist (basiliximab) induction therapy is associated with lower morbidity and mortality in renal transplant recipients

Author: Choy B.Y.   Chan T.M.   Li F.K.   Lui S.L.   Lo W.K.   Yip T.   Tse K.C.   Lai K.N.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.35, Iss.1, 2003-02, pp. : 195-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content